Cleft lip and palate (CLP) is a common anomaly of the orofacial region. Mesenchymal stem cell (MSC) transplantation has been a focus of regenerative medicine, and its application to the repair of bone defects in patients with CLP is highly anticipated. This study investigated the potential for using MSCs to regenerate bone in a jaw cleft as well as the survival of transplanted MSCs using a canine model of CLP.
Design:
Mesenchymal stem cells collected from the bone marrow of beagle dogs were transplanted along with carbonate hydroxyapatite into jaw clefts in beagle dogs. Mesenchymal stem cells labeled with fluorescent silica nanoparticles were also transplanted, and a histological analysis was performed 3 months later to evaluate MSC survival.
Results:
Carbonate hydroxyapatite regeneration into bone was enhanced by cotransplantation of MSCs. The survival rate of MSCs transplanted after 3 months was 5.7%.
Conclusions:
Transplanted MSCs promote bone regeneration, although their survival rate is low.
AbeTSumiKKunimatsuROkiNTsukaYNakajimaKTanimotoK. Dynamic imaging of the effect of mesenchymal stem cells on osteoclast precursor cell chemotaxis for bone defects in the mouse skull. J Dent Sci. 2018;13(4):354–359.
2.
AukhilI. Biology of wound healing. Periodontol 2000. 2000;22:44–50.
3.
Beck-CoonRJNewtonCWKafrawyAH. An in vivo study of the use of a nonresorbable ceramic hydroxyapatite as an alloplastic graft material in periapical surgery. Oral Surg Oral Med Oral Pathol. 1991;71(4):483–488.
4.
BerglandOSembGAbyholmFE. Elimination of the residual alveolar cleft by secondary bone grafting and subsequent orthodontic treatment. Cleft Palate J. 1986a;23(3):175–205.
5.
BerglandOSembGAbyholmFBorchgrevinkHEskelandG. Secondary bone grafting and orthodontic treatment in patients with bilateral complete clefts of the lip and palate. Ann Plast Surg. 1986b;17(6):460–474.
6.
BoynePJSandsNR. Secondary bone grafting of residual alveolar and palatal clefts. J Oral Surg. 1972;30(2):87–92.
7.
CaplanAI. The mesengenic process. Clin Plast Surg. 1994;21(3):429–435.
8.
CuiLLiuBLiuGZhangWCenLSunJYinSLiuWCaoY. Repair of cranial bone defects with adipose derived stem cells and coral scaffold in a canine model. Biomaterials. 2007;28(36):5477–5486.
9.
EnemarkHSindet-PedersenSBundgaardM. Long-term results after secondary bone grafting of alveolar clefts. J Oral Maxillafac Surg. 1987;45(11):913–918.
10.
FeinbergSEVittM. Effect of calcium phosphate ceramic implants on tooth eruption. J Oral Maxillofac Surg. 1998;46(2):124–127.
11.
GnecchiMZhangZNiADzauVJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008;103(11):1204–1219.
12.
HasegawaNKawaguchiHHirachiATakedaKMizunoNNishimuraMKoikeCTsujiKIbaHKatoY, et al.Behavior of transplanted bone marrow-derived mesenchymal stem cells in periodontal defects. J Periodontol. 2006;77(6):1003–1007.
13.
HossainMZKyomenSTanneK. Biologic responses of autogenous bone and beta-tricalcium phosphate ceramics transplanted into bone defects to orthodontic forces. Cleft Palate Craniofac J. 1996;33(4):277–283.
14.
ImanishiYMiyagawaSKitagawa-SakakidaSTaketaniSSekiyaNSawaY. Impact of synovial membrane-derived stem cell transplantation in a rat model of myocardial infraction. J Artif Organs. 2009;12(3):187–193.
15.
KagiwadaHYashikiTOhshimaATadokoroMNagayaNOhgushiH. Human mesenchymal stem cells as a stable source of VEGF-producing cells. J Tissue Eng Regen Med. 2008;2(4):184–189.
16.
KakuMTaiMKawataTFujitaTMotokawaMOhtaniJSakaiYKatoYTanneK. Mesenchymal stem cell-induced cranial suture-like gap in rats. Plast Reconstr Surg. 2011;127(1):69–77.
17.
KinnairdTStabileEBurnettMSShouMLeeCWBarrSFuchsSEpsteinSE. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation. 2004;109(12):1543–1549.
18.
KnightMNHankensonKD. Mesenchymal stem cells in bone regeneration. Adv Wound Care (New Rochelle). 2013;2(6):306–316.
19.
KuboTDoiKHayashiKMoritaKMatsuuraATeixeiraERAkagawaY. Comparative evaluation of bone regeneration using spherical and irregularly shaped granules of interconnected porous hydroxylapatite. A beagle dog study. J Prosthodont Res. 2011;55(2):104–109.
20.
LacoFKunMWeberHJRamakrishnaSChanCK. The dose effect of human bone marrow-derived mesenchymal stem cells on epidermal development in organotypic co-culture. J Dermatol Sci. 2009;55(3):150–160.
21.
LeikerMSuzukiGVijaySCantyJMJrLeeT. Assessment of a nuclear affinity labeling method for tracking implanted mesenchymal stem cells. Cell Transplant. 2008;17(8):911–922.
22.
LiGSimpsonAHKenwrightJTriffittJT. Assessment of cell proliferation in regenerating bone during distraction osteogenesis at different distraction rates. J Orthop Res. 1997;15(5):765–772.
23.
LianJBSteinGS. Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation. Crit Rev Oral Biol Med. 1992;3(3):269–305.
24.
MatsuuraAKuboTDoiKHayashiKMoritaKYokotaRHayashiHHirataIOkazakiMAkagawaY. Bone formation ability of carbonate apatite-collagen scaffolds with different carbonate contents. Dent Mater J. 2009;28(2):234–242.
25.
MbalavieleGJaiswalNMengAChengLVan Den BosCThiedeM. Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors. Endocrinology. 1999;140(8):3736–3743.
26.
NatsumeNSuzukiTKawaiT. The prevalence of cleft lip and palate in Japanese. Br J Oral Maxillofac Surg. 1988;26(3):232–236.
27.
OkiNAbeTKunimatsuRSumiKAwadaTTsukaYNakajimaKAndoKTanimotoK. The role of vascular endothelial growth factor and mesenchymal stem cells during angiogenesis. Biomed Res. 2018;29(15):3079–3084.
28.
OshimaYWatanabeNMatsudaKTakaiSKawataMKuboT. Behavior of transplanted bone marrow-derived GFP mesenchymal cells in osteochondral defect as a simulation of autologous transplantation. J Histochem Cytochem. 2005;53(2):207–216.
29.
OsugiMKatagiriWYoshimiRInukaiTHibiHUedaM. Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects. Tissue Eng Part A. 2012;18(13-14):1479–1498.
30.
SumiKAbeTKunimatsuROkiNTsukaYAwadaTNakajimaKAndoKTanimotoK. The effect of mesenchymal stem cells on chemotaxis of osteoclast precursor cells. J Oral Sci. 2018;60(2):221–225.
31.
WagnerWSaffrichRHoAD. The stromal activity of mesenchymal stromal cells. Transfus Med Hemother. 2008;35(3):185–193.
32.
WagnerWWeinFRoderburgCSaffrichRFaberAKrauseUSchubertMBenesVEcksteinVMaulH, et al.Adhesion of hematopoitic progenitor cells to human mesenchymal stem cells as a model for cell-cell interaction. Exp Hematol. 2007;35(2):314–325.
33.
WalendaTBokermannGVentura FerreiraMSPirothDMHieronymusTNeussSZenkeMHoADMüllerAMWagnerW. Synergistic effects of growth factor and mesenchymal stromal cells for expansion of hematopoietic stem and progenitor cells. Exp Hematol. 2011;39(6):617–628.
34.
YonenoKOhnoSTanimotoKHondaKTanakaNDoiTKawataTTanakaEKapilaSTanneK. Multidifferentiation potential of mesenchymal stem cells in three-dimensional collagen gel cultures. J Biomed Mater Res. 2005;75(3):733–741.
35.
YonenoKTanakaEOhnoSTanimotoK. Hyaluronic acid promotes osteochondrogenic differentiation from mesenchymal stem cells in a three-dimensional culture system. J Stem Cells. 2007;2(3):149–158.
36.
YoshikawaTOhgushiHTamaiS. Immediate bone forming capability of prefabricated osteogenic hydroxyapatite. J Biomed Mater Res. 1996;32(3):481–492.
37.
YoshiokaMTanimotoKTanneYSumiKAwadaTOkiNSugiyamaMKatoYTanneK. Bone regeneration in artificial jaw cleft by use of carbonated hydroxyapatite particles and mesenchymal stem cells derived from iliac bone. Int J Dent. 2012;2012:352510.
38.
ZhangDChuFYangYXiaLZengDUludağHZhangXQianYJiangX. Orthodontic tooth movement in alveolar cleft repaired with a tissue engineering bone: an experimental study in dogs. Tissue Eng Part A. 2011;17(9-10):1313–1325.
39.
ZhouJLinHFangTLiXDaiWUemuraTDongJ. The repair of large segmental bone defects in the rabbit with vascularized tissue engineered bone. Biomaterials. 2010;31(6):1171–1179.
